Objectives-To evaluate the feasibility of the ultrafast ultrasound pulsed wave velocity (PWV) for carotid stiffness assessment and potential influencing factors.
A therosclerosis is a complex process involving a combination of lipid deposition (structural) and vessel stiffening (functional) changes of the arterial wall. The carotid intima-media thickness (IMT) is a well-accepted and commonly used surrogate marker for structural changes and a predictor of cardiovascular disease. 1 Aortic arterial stiffness, assessed as the carotid-femoral pulsed wave velocity (PWV), has been shown to correlate well with excess morbidity and mortality independently of other cardiovascular risk factors. 2, 3 The carotid-femoral PWV is a reference standard method for assessment of segmental stiffness in the aortic tree, and the latest European guideline has recommended integration of the carotid-femoral PWV for the management of arterial hypertension. 4 However, an evaluation of the carotid-femoral PWV requires dedicated equipment and is time-consuming, which limits its clinical practice. Moreover, its accuracy has been called into question because the errors of distance measurement and pulse transit time estimation. 5, 6 Due to the context of its inability to assess local arterial stiffness, many new technologies, mainly derived from ultrasound (US) and magnetic resonance imaging, have been proposed to assess the local artery PWV. [7] [8] [9] Specifically, the local stiffness of the carotid artery, particularly in association with cardiovascular disease, has been investigated. A recent meta-analysis reported that carotid stiffness was positively associated with the stroke incidence, regardless of age, sex, blood pressure, and other cardiovascular disease risk factors. 10 Nevertheless, a systematic literature review showed that these modalities, parameters, and units used to express carotid stiffness make it challenging to compare results among these studies due to non-unified technique criteria and reference values. 9 Thus, their clinical applicability is hampered as well.
Recently, a new imaging technique embedded into a conventional vascular Doppler US apparatus, termed ultrafast US imaging, 11 has been developed. The ultrafast PWV is characterized by an extremely high imaging frame rate, which is up to 10,000 frames per second and 100 times faster than conventional US imaging devices currently available. 12, 13 This property enables it to capture the local PWV of the carotid artery not only at the aortic valve opening (early systole) but also at the aortic valve closure (end systole). 11, 14 To date, few studies have used the technology to evaluate the PWV of the local carotid artery, which showed that it was a promising method with high accuracy and reproducibility. [13] [14] [15] [16] [17] However, the patients enrolled in these studies were either healthy volunteers or subclinical atherosclerosis populations.
To our knowledge, there have been no reports on the overall feasibility of the ultrafast PWV in both healthy populations and atherosclerotic patients. Therefore, the purpose of this study was to evaluate the feasibility of the ultrafast PWV in a healthy population and patients at different stages of atherosclerosis. Additionally, potential equipment and carotid factors influencing the ability to obtain an ultrafast PWV measurement were assessed as well.
Materials and Methods

Patients
This prospective study was approved by the Institutional Review Board, and written informed consent was obtained from all participants. Between January 2017 and June 2017, carotid ultrafast PWV measurement was performed in 162 consecutive patients (patient group). All patients had 1 or more atherosclerotic risk factors. The following criteria were used for atherosclerotic risk factors. Hypertension was defined as systolic blood pressure of 140 mm Hg or higher, diastolic blood pressure of 90 mm Hg or higher, or both, and the use of antihypertensive drugs. The criteria for diabetes were a fasting plasma glucose level of 7.0 mmol/L or higher, an oral glucose tolerance test 2-hour postprandial glucose level of 11.1 mmol/L or higher, or both, or treatment for diabetes. Hyperlipidemia was defined as a total cholesterol level of 5.7mmol/dL or higher, a triglyceride level of 1.7 mmol/L or higher, or both, or the use of antihyperlipidemic drugs. Chronic kidney disease was defined as a urinary albumin-to-creatinine ratio of greater than 30 mg/g, a glomerular filtration rate of less than 60 ml/ min/1.73 m 2 , or both. In addition, smoking was defined as consuming at least 1 cigarette daily. During the same interval, 66 healthy volunteers who visited our hospital for physical examinations were also enrolled as a control group. All volunteers were free of atherosclerotic risk factors.
Conventional US and Ultrafast PWV Acquisitions
Conventional US and ultrafast PWV acquisitions were performed by a single radiologist (F.P.) with an Aixplorer ultrafast US imaging system (SuperSonic Imagine, Aix-en-Provence, France) equipped with SL15-4 (frequency, 4-15 MHz; footprint, 50 mm) and SL10-2 (frequency, 2-10 MHz; footprint, 38 mm) transducers. Ultrafast PWV measurement was consistent with previous studies. 13, 15, 16 We scanned the first 110 carotid segments with both transducers, whereas the remaining patients were scanned only with the SL15-4 transducer. In a supine position with the head tilted slightly to the contralateral side, the transducer was located with its upper end approximately 2cm proximal to the carotid flow divider. In B-mode US with a good view of the intima-media layers, ensuring a short patient breath hold, the ultrafast imaging acquisition was activated, the processing of which occupies the system for few seconds. The system automatically deduces the propagation velocities of the pulsed waves at the beginning and end of systole, and their standard deviations (expressed as D6; Figure 1 ). To follow a uniform protocol, the width of the region of interest (ROI; box size in Figure 1 ) was adjusted to the field of view of the transducer. A valid acquisition was defined as the simultaneous display of the PWV before systole, PWV at the end of systole, and D 6 of less than 20% of the corresponding PWV before systole or at the end of systole. Otherwise, the acquisition was defined as invalid. Three valid ultrafast PWV measurements, which were deemed to be an ultrafast PWV success, were obtained and averaged in the final data analysis. The ultrafast PWV measurement was deemed to be a failure when the first 3 consecutive acquisitions were all invalid. For the first 110 carotid segments, conventional US and ultrafast PWV data based only on the SL15-4 transducer were used in the final overall analysis.
For conventional US, the carotid variables in the scanned segment of the ultrafast PWV, including IMT, carotid diameter (vertical distance from intima to intima), depth (vertical distance from the skin to the anterior adventitia of the carotid), peak systolic velocity, end diastolic velocity, and resistive index, were measured. Specifically, the far IMT was automatically measured by using an Aixplorer tool when an optimal Bmode image allowed a clear depiction of the intimamedia layers; otherwise, the IMT was measured manually at the thickest site in the zoom pattern on B-mode US imaging. In the cases with carotid plaque, which was defined as focal region with a maximal IMT of 1.5 mm or greater, 18 the maximal thickness of the plaque was recorded as the IMT.
Statistical Analysis
The statistical analysis was performed with MedCalc version 11.2 software (MedCalc, Mariakerke, Belgium). P < .05 was accepted as indicating statistical significance. The 1-sample Kolmogorov-Smirnov test was used to test the normal distribution of the quantitative variables. When the quantitative variables were normally distributed, the results were described as mean values and standard deviations; otherwise, medians and interquartile ranges (25th-75th percentiles) were recorded. The qualitative variables were summarized as counts and percentages. Between-group comparisons were performed by the t test or Mann-Whitney test for normally and non-normally distributed data, respectively. Comparisons of clinical, US, and ultrafast PWV characteristics of the groups were performed by the vevaluate the intra-observer reproducibility by BlandAltman plots or intraclass correlation coefficients (ICCs). In addition, a generalized linear mixed-effects model was performed to determine which transducer had the greater ability to obtain the ultrafast PWV measurement. 19 Based on this model, failure or success of the ultrafast PWV acquisition was the outcome; the fixed variable was the transducer bandwidth; and the random variables were the indication for each enrolled patient and the indication for each carotid segment. Finally, a multiple logistic regression analysis, with a forward stepwise method for selection of significant variables, was performed to determine independent predictors of failure of the ultrafast PWV measurement from the carotid US features that showed statistical significance (P < .05).
Results
Basic Characteristics of the Study Population and Carotid Arteries
The basic characteristics of the study population and carotid segments are listed in Table 1 . The mean age (57.1 6 14.2 versus 44.9 6 15.1 years) was older in the patient group than in the control group (P < .05). In the patient group, 96, 112, 35, and 73 patients had hypertension, type 2 diabetes, chronic kidney disease, and hyperlipidemia, respectively. Moreover, 39 patients had a smoking habit. Carotid ultrafast PWV and conventional US measurements were performed on both the left and right sides in all of the enrolled cases except 14 cases in the patient group, in which measurements were obtained on one side because of jugular vein catheter placement (n 5 1), severe media calcification (n 5 3), which influenced the evaluation of the IMT, a highly pulsatile internal jugular vein (n 5 2), internal or common carotid stenosis of 50% or greater (n 5 5), and occlusion of the internal or common carotid artery (n 5 3). Thus, data from 442 carotid arteries were enrolled in the final analysis. Each carotid ultrafast PWV acquisition was completed within 1 minute. There was no evidence of IMT of greater than 0.95 mm in the control group, whereas there were 58 carotid segments with the presence of plaque in the patient group.
Comparison and Relationship of the IMT and Ultrafast PWV The IMT, PWV before systole, and PWV at the end of systole between the patient and control groups were compared ( Table 2 ). The IMT, PWV before systole, and PWV at the end of systole were significantly greater in the patient group than in the control group (all P < .001). The IMT was positively correlated with the PWV before systole and at the end of systole (r 5 0.357-0.771; all P < .001) in both the control and patient groups. Furthermore, the total success of the ultrafast PWV acquisitions was classified into 3 subgroups based on the IMT: IMT of 0.9 mm or less (n 5 271), IMT of 0.9 to mm (n 5 76), and IMT of 1.5 mm or greater (n 5 28). In the IMT subgroup analysis, the IMT had a positive correlation with the PWV both before and at the end of systole (r 5 0.207-0.553; all P < .05) for the subgroups with IMTs of 0.9 mm or less and 0.9 to 1.5 mm, whereas no correlation was found between the IMT and PWV before or at the end of systole (both P > .05) for the subgroup with an IMT of 1.5 mm or greater.
Reproducibility of Ultrafast PWV Measurements Based on the SL15-4 Transducer
Among the 375 valid ultrafast PWV measurements obtained by the SL15-4 transducer, the intraobserver variability showed a high degree of consistency ( Figure  2) , with mean differences of 0.12 6 1.28 m/s for the PWV before systole and 0.06 6 1.30 m/s for the PWV at the end of systole. Additionally, the ICCs were 0.817 for the PWV before systole and 0.930 for the PWV at the end of systole. 0.14 6 0.79 m/s for the PWV at the end of systole (Figure 3) . However, the success rate of the SL15-4 transducer was higher than that of SL10-2 transducer for carotids with an IMT of less than 1.5 mm (both P < .05). Identically, the generalized linear mixed-effects model analysis showed that the SL15-4 transducer had a greater ability to obtain valid ultrafast PWV measurement than the SL10-2 transducer for carotids with an IMT of less than 1.5 mm (Table 4 ; both P < .05). With regard to the intraobserver reproducibility of the PWV before and at the end of systole, the ICC for the SL15-4 transducer was slightly higher than that for the SL10-2 transducer.
The carotid features between the ultrafast PWV success and failure groups were compared as well ( Table  5 ). The failure group had a wider carotid diameter, lower peak systolic velocity, thicker IMT, and higher rate of plaque presence (all P < .05). A multiple logistic regression analysis was performed to determine independent carotid factors for predicting failure of the ultrafast PWV measurement ( Table 6 ). The IMT, especially plaque, showed a significant association with failure of the measurement (P < .001).
Discussion
To our knowledge, this work was the first study to evaluate the feasibility of the ultrafast PWV in both a healthy population and patients at different stages of atherosclerosis. We have demonstrated that carotid stiffness measured by the ultrafast PWV was positively correlated with the IMT in both normal and relatively early atherosclerotic carotid arteries. The IMT, especially plaque, showed a significant association with failure of the ultrafast PWV measurement. Additionally, ultrafast PWV measurements were more likely obtained with the SL15-4 transducer when the IMT was less than 1.5 mm.
Arterial stiffening is a systemic process that affects other peripheral arteries than the central artery. Both aorta and carotid stiffnesses were associated with the degree of atherosclerosis and were interrelated. 20 However, previous studies have reported that diverse cardiovascular disease risk factors may differentially affect the stiffness at different artery sites. 20, 21 Moreover, it has been suggested that the aorta stiffens more than the carotid artery with age and other cardiovascular risk factors. 20 This context suggests that it might be Data are expressed as median (interquartile range) and mean 6 SD where applicable. EDV indicates end-diastolic velocity; PSV, peak systolic velocity; and RI, resistive index. 10, 20, 22 In a systematic literature review, 9 various methods were used to evaluate carotid stiffness; however, these methods might be time-consuming or require dedicated equipment. Moreover, it was difficult to compare results among these studies because of different technique criteria and reference values. These factors provide justification for fostering an effective and userfriendly method to evaluate carotid stiffness.
In this study, a recently new method, ultrafast US imaging, was applied to evaluate carotid stiffness. The ultrafast PWV has the following advantages. First, the ultrafast PWV and conventional US are implemented in the same machine, and the ultrafast PWV measurement is a single-key process instead of requiring a high level of technical expertise. Second, it is time saving. In our study, each carotid ultrafast PWV acquisition was completed within 1 minute. Third, a previous study reported that the systolic PWV may be more suitable for a quantifiable evaluation of arterial stiffness than the diastolic PWV. 23 Both the PWV before systole and PWV at the end of systole represented the systolic PWV. Fourth, the ultrafast PWV measurement is not influenced by errors in distance assessment between measurement sites.
The success rate of the ultrafast PWV decreased with the increase of the IMT, which was lower than in previous studies. [15] [16] [17] There were 58 carotids with the presence of plaque in our study, whereas the carotids enrolled in previous studies were either from healthy volunteers or subclinical atherosclerosis populations. Thus, different enrollment criteria could be an explanation for this difference. Furthermore, the width of the ROI was the same as that of the transducer in our study, whereas it was not mentioned in previous studies, [15] [16] [17] which might be another reason for the difference in success rates. Interestingly, an apparently invalid ultrafast PWV measurement can be overcome by reducing the width of the ROI. Thus, the most appropriate width of the ROI needs to be studied further. Despite the relatively lower success rate of the ultrafast PWV in carotids with plaque, the overall intraobserver variability showed a high degree of consistency, which was in line with previous findings. 14, 16, 17 In our study, both the PWV before systole and PWV at the end of systole were positively correlated with the IMT in carotids without plaque, which suggested that ultrafast US imaging might be a suitable device for measuring the IMT and local carotid stiffness parameters, at least in normal and relatively early atherosclerotic carotids. Additionally, we found no correlation between the IMT and PWV before or at the end of systole in carotids with plaque, which suggested that functional changes in the arterial wall might not parallel structural changes. A study documented that structural changes were more advanced than functional changes in type 2 diabetes. 24 However, given that the carotid ultrafast PWV acquisitions were performed on both the left and right sides, bilateral carotids have the same clinical features in the same patient. Thus, the different effects of independent atherosclerotic risk factors and age on the IMT and PWV were not analyzed and adjusted in our study. Therefore, more studies are needed to validate the relationship between the ultrafast PWV and IMT in a population with specific atherosclerotic risk factors.
With regard to the potential influencing factors for the ability to obtain the ultrafast PWV measurement, we focused on the carotid and equipment factors instead of atherosclerotic factors. Although most published studies in a systematic literature review supported the idea that artery stiffness increased with the presence of plaque regardless of which method was used, 9 few data have reported the influence of plaque on the ability to obtain an ultrafast PWV measurement. In this study, we found that the IMT, especially plaque, showed a significant association with failure of the ultrafast PWV measurement. We speculated that the following reasons might explain our findings. First, the pulsed wave has a large wavelength, and arterial plaque may influence propagation of the wave. Additionally, an increased IMT or plaque may influence precise tracing and delineation of the carotid wall. Finally, although we tilted the patient's head to the contralateral side to ensure a straight carotid that was parallel to the transducer, a few carotids were still relatively tortuous, which may have influence precisely tracing and delineation of the carotid wall as well.
In this study, the success rate of the SL15-4 transducer was higher than that of SL10-2 transducer for carotids without plaque. Meanwhile, the generalized linear mixed-effects model analysis showed that the SL15-4 transducer had a greater ability to obtain valid ultrafast PWV measurements. With regard to the intraobserver reproducibility of the PWV before and at the end of systole, the ICC for the SL15-4 transducer was slightly higher than that for the SL10-2 transducer. Additionally, the depth difference of carotids between the success and failure groups was not statistically significant. Given the fact that the successful acquisition of the ultrafast PWV was based on a clear display of the intima-media on Bmode US imaging, the SL15-4 transducer with a relatively high frequency has a correspondingly high resolution, which might be an important explanation for our findings. Therefore, our results indicated that the ultrafast PWV measurements were more likely obtained with the SL15-4 transducer for carotids with an IMT of less than 1.5 mm.
This study had some limitations. First, we did not compare ultrafast US imaging to other imaging modalities for measuring local carotid stiffness. Although there are many modalities for measuring carotid stiffness, it is challenging to compare them directly because of nonunified technique criteria and units. The ultrafast PWV imaging protocol adopted in our study would easily have permitted measurement of carotid distensibility, a local measure of carotid stiffness. Second, the sample size was relatively small; thus, our findings need to be validated in larger multicenter trial. Third, the IMT was measured manually rather than automatically in cases with an IMT of greater than 1.2 mm or carotid plaque, which may have resulted in a measurement bias. Fourth, aging is a major determinant of arterial stiffness and the IMT; the study design involved the enrollment of consecutive patients instead of selecting patients by an age-matching process. Last, although the ultrafast PWV measurement is a single-key automatic process, we only evaluated the intraobserver rather than the interobserver variability.
In conclusion, the ultrafast PWV is an effective and user-friendly alternative method to evaluate carotid stiffness in both normal and relatively early atherosclerotic carotids. The IMT and transducer bandwidth are factors influencing the ultrafast PWV measurement. Additionally, the most appropriate width of the ROI needs to be studied further.
